CMV-NEUTRALISIERENDE ANTIGENBINDENDE PROTEINE

European patent · EP3445393 · In force

Register entry

Publication number
EP3445393
Application number
EP17786443
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 18, 2017
Published
Feb 27, 2019
Granted
Jan 14, 2026
Protection ends at the latest
Apr 17, 2037
Next annual fee due
Apr 30, 2026
IPC classes
C07K 16/08 (2026.01)
A61K 39/00 (2006.01)
A61K 39/245 (2006.01)
A61K 39/395 (2006.01)
A61K 39/42 (2006.01)
C12N 7/00 (2006.01)
C12P 21/00 (2006.01)
Priority
US 201662324952 P 20.04.2016
PCT application
PCT/US2017/028062 18.04.2017
PCT publication
WO2017/184562 26.10.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 14, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 14.01.2026

Parties

Inventor

FU, Tong-Ming

West Point, Pennsylvania 19486, US

TANG, Aimin

West Point, Pennsylvania 19486, US

WANG, Dai

West Point, Pennsylvania 19486, US

AN, Zhiqiang

Austin, Texas 78701, US

ZHANG, Ningyan

Austin, Texas 78701, US

HA, Sha

West Point, Pennsylvania 19486, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.